Tag: DurAVR Transcatheter Heart Valves
FDA OKs manufacturing of Anteris’ aortic valve replacement at Minnesota facility
Anteris Technologies announced that the US Food and Drug Administration (FDA) has approved the manufacturing of DurAVR THV, a 3D single-piece aortic heart valve replacement, at the company's recently expanded production facility in Maple Grove, Minnesota.
Featured Article
A business-led approach to maximising your SAP investment
Manufacturers are responding to the low-growth environment by focusing on digitisation, ESG and portfolio reshaping, transforming into more digital, resilient, and sustainable organisations.
